JOURNAL OF PRACTICAL HEPATOLOGY ›› 2019, Vol. 22 ›› Issue (3): 449-452.doi: 10.3969/j.issn.1672-5069.2019.03.035
• Review • Previous Articles Next Articles
Zhang Tingting, Wang Xuan
Received:
2018-02-05
Online:
2019-05-10
Published:
2019-05-15
Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[1] Muting D,Wohlgemuth D,Dorsett R.Liver cirrhosis and diabetes mellitus. Geriatrics,1969,24(1):91-99. [2] HickmanIJ,MacdonaldGA. Impact of diabetes on the severity of liver disease. Am J Med,2007,120(10):829-834. [3] Falchuk KR,Fiske SC,Haggitt RC,et al.Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology,1980,78(3):535-541. [4] Nishida T,Tsuji S,Tsujii M,et al.Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol,2006,101(1):70-75. [5] Imano E,Nishida T,Shibata M,et al.Significance of oral glucose tolerance test for the diagnosis of diabetes mellitus in patients with liver cirrhosis. Intern Med,1999,38(11):918. [6] Roden M,Bernroider E.Hepatic glucose metabolism in humans: its role in health and disease. Best Pract Res Clin Endocrinol Metab,2003,17(3):365-383. [7] Sinacore DR,Gulve EA.The role of skeletal muscle in glucose transport,glucose homeostasis,and insulin resistance:implications for physical therapy. Phys Ther,1993,73(12):878-891. [8] Krssak M,Brehm A,Bernroider E,et al.Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes,2004,53(12):3048-3056. [9] Imano E,Kanda T,Nakatani Y,et al.Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol,1999,31(3):469-473. [10] Cavallo-Perin P,Cassader M,Bozzo C,et al.Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest,1985,75(5):1659-1665. [11] Shmueli E,Walker M,Alberti G,et al.Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis. Hepatology,1993,18(1):86-95. [12] Shanik MH,Xu Y,Skrha J,et al. Insulin resistance and hyperinsulinemia:is hyperinsulinemia the cart or the horse Diabetes Care,2008,31(Suppl 2):S262-S268. [13] Huang JF,Dai CY,Hwang SJ,et al.Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area:an epidemiological link with virological implication. Am J Gastroenterol,2007,102(6):1237-1243. [14] Shintani Y,Fujie H,Miyoshi H,et al.Hepatitis C virus infection and diabetes:direct involvement of the virus in the development of insulin resistance. Gastroenterology,2004,126(3):840-848. [15] Pazienza V,Clément S,Pugnale P,et al.The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology,2007,45(5):1164-1171. [16] Davuluri G,Krokowski D,Guan BJ,et al.Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of L-leucine in cirrhosis. J Hepatol,2016,65(5):929-937. [17] Garcia-Compean D,Jaquez-Quintana JO,Gonzalez-Gonzalez JA, et al.Liver cirrhosis and diabetes:risk factors,pathophysiology,clinical implications and management. World J Gastroenterol,2009,15(3):280-288. [18] Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care,1997,20(7):1183-1197. [19] International Expert Committee.International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care,2009,32(7):1327-1334. [20] Picón MJ,Murri M,Munoz A,et al.Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening. Diabetes Care,2012,35(8):1648-1653. [21] Kanda T,Nakamura M,Iwasaki M,et al.Clinical significance of HbA1c,serum fructosamine and 1,5-AG in diabetic patients complicated with liver cirrhosis. J Jpn Diabetes Soc,1993,36:847-854. [22] Panzer S,Kronik G,Lechner K,et al.Glycosylated hemoglobins (GHb):an index of red cell survival. Blood,1982,59(6):1348-1350. [23] Koga M,Kasayama S,Kanehara H,et al.CLD (chronic liver diseases):HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract,2008,81(2):258-262. [24] Matsumoto N,Arase Y,Seko Y,et al.Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL. Hepatol Res,2012,42(6):558-563. [25] Holstein A,Hinze S,Thiessen E,et al.Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol,2002,17(6):677-681. [26] Jeon HK,Kim MY,Baik SK,et al.Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci,2013,58(11):3335-3341. [27] Fukui H,Saito H,Ueno Y,et al.Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol,2016,51(7):629-650. [28] Merli M,Leonetti F,Riggio O,et al.Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology,1999,30(3):649-654. [29] D’Amico G,Garcia-Tsao G,Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis:a systematic review of 118 studies. J Hepatol,2006,44(1):217-231. [30] Krige JE,Kotze UK,Bornman PC,et al.Variceal recurrence,rebleeding,and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg,2006,244(5):764-770. [31] Zoppini G,Fedeli U,Gennaro N,et al.Mortality from chronic liver diseases in diabetes. Am J Gastroenterol,2014,109(7):1020-1025. [32] Bianchi G,Marchesini G,Zoli M,et al.Prognostic significance of diabetes in patients with cirrhosis. Hepatology,1994,20(pt 1):119-125. [33] Moreau R,Delègue P,Pessione F,et al.Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int,2004,24(5):457-464. [34] García-Compeán D,Jáquez-Quintana JO, Lavalle-González FJ,et al.Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis. World J Gastroenterol,2014,20(22):7011-7018. [35] Sangiovanni A,Prati GM,Fasani P,et al.The natural history of compensated cirrhosis due to hepatitis C virus:a 17-year cohort study of 214 patients. Hepatology,2006,43(6):1303-1310. [36] Elkrief L,Rautou PE,Sarin S,et al.Diabetes mellitus in patients with cirrhosis:clinical implications and management. Liver Int,2016,36(7):936-948. [37] Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma. Lancet,2012,379(9822):1245-1255. [38] Yang WS,Va P,Bray F,et al.The role of preexisting diabetes mellitus on hepatocellular carcinoma occurrence and prognosis:a Meta-analysis of prospective cohort studies. PLoS One,2011,6(12):e27326. [39] Tsugane S,Inoue M.Insulin resistance and cancer:epidemiological evidence. Cancer Sci,2010,101(5):1073-1079. [40] Veldt BJ,Chen W,Heathcote EJ,et al.Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology,2008,47(6):1856-1862. [41] Tung HD,Wang JH,Tseng PL,et al.Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area:community cross-sectional and case-control studies. Am J Gastroenterol,2010,105(3):624-631. [42] Takahashi H,Mizuta T,Eguchi Y,et al.Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. J Gastroenterol,2011,46(6):790-798. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||